Opexa Therapeutics, Inc. (NASDAQ:OPXA) Stock Quotes and News

Opexa Therapeutics, Inc. (OPXA) 1.50 -0.19

Price Open:	1.65	Day's Range:	0.00000 - 5.59000
Price Close:	1.68	52wk Range:	0.00000 - 5.59000
Price Day Change:	-0.19	Volume:	605,782
Price % Change:	-11.31	Market Cap:	12.0M
Bid:	1.41000	PE Ratio:	0
Ask:	1.50000	EPS Diluted:	-1.744

Trade OPXA NOW!

The Latest On OPXA

Mid-Afternoon Market Update: Markets Settle a Bit as 3D Printing Names Rally 5/14/13 3:54pm

Mid-Day Market Update: US Stocks Continue Rally, Large Cap Banks See Biggest Advances 5/14/13 1:38pm

Morning Market Losers 5/14/13 10:09am

Earnings Scheduled For May 14, 2013 5/14/13 5:02am

Small Cap Biotech Hot Again: How To Play It 4/22/13 2:03pm

Friday's Stocks to Watch, Mar 15 3/15/13 8:58am

Benzinga's Small Cap Movers for Tuesday March 12, 2013 3/12/13 6:08pm

Opexa Therapeutics Prices ~1.083M Units at $3/Unit 2/7/13 10:05am

Opexa Therapeutics Announces Pricing of Common Stock and Warrant Offering 2/7/13 10:00am

Benzinga's Small Cap Movers for Tuesday February 5, 2013 2/5/13 9:28pm

Merck Serono, Opexa Therapeutics Enter Option, License Agreement for Development of Tcelna 2/5/13 8:41am

Opexa Announces Agreements for up to $16.5 Million in Equity Commitments 11/5/12 6:20pm

Press Releases

Opexa Therapeutics Recognizes World MS Day and Will Present Poster With Secondary Progressive Multiple Sclerosis Data at CMSC / ACTRIMS Annual Meeting 5/29/13 Business Wire

In Honor of World MS Day Opexa Therapeutics to Ring The NASDAQ Stock Market Closing Bell on May 28 5/28/13 Business Wire

Opexa Therapeutics Reports First Quarter 2013 Financial Results and Provides Corporate Update 5/14/13 Business Wire

Opexa Therapeutics Announces News Release and Conference Call Schedule to Discuss First Quarter 2013 Financial Results 5/10/13 Business Wire

The Vatican's Pontifical Council for Culture, NeoStem, The Stem for Life Foundation & STOQ International Host 2nd International Vatican Adult Stem Cell Conference 4/11/13 GlobeNewswire

Opexa Therapeutics to Present at the Regenerative Medicine - A Fundamental Shift in Science & Culture Conference 4/4/13 Business Wire

Opexa Therapeutics Announces Changes to Senior Management Team 4/1/13 Business Wire

Opexa Therapeutics Reports Year End 2012 Financial Results and Provides Corporate Update 3/28/13 Business Wire

The Vatican's Pontifical Council for Culture, NeoStem, The Stem for Life Foundation & STOQ International Announce Highlights of the Upcoming Second International Adult Stem Cell Conference 3/22/13 GlobeNewswire

Opexa Therapeutics to Present at the 6th Annual European Life Science CEO Forum 3/4/13 Business Wire

Opexa Therapeutics, Inc. Announces Pricing of Common Stock and Warrant Offering 2/7/13 Business Wire

Opexa Therapeutics to Present at the 15th Annual BIO CEO & Investor Conference 2/7/13 Business Wire

Get the latest OPXA stock news on the web. Get the latest stock quotes and much more - Benzinga is the source for Opexa Therapeutics, Inc. stock price.

Partner Headlines

And This is Just the Beginning for Opexa Therapeutics (OPXA)... 3/26/13

Opexa Therapeutics (OPXA) is Ready to Restart the Effort, This Time the Right Way 3/19/13

Opexa Therapeutics Inc. Reports Operating Results (10-Q) 11/14/12

A David & Goliath Story Setting Up on the MS Front (NVS, OPXA, BIIB) 10/4/12

Three Stocks That Aren't Terrifying to Buy Now: OPXA, AONE, NXPI in Focus 9/12/12

Three Stocks Close to Becoming Heroes: APKT, GNOM, OPXA 8/29/12

Conmed Healthcare Management, Zogenix Among Stocks Gapping Up Monday 7/16/12

Opexa Therapeutics Inc. Reports Operating Results (10-K) 2/27/12

Opexa Therapeutics Inc. Reports Operating Results (10-Q) 11/4/11

Versar, Opexa Therapeutics: Midday Volume Plays

Biotech Stock Mailbag: Vertex Pharma